The role of thrombopoietin (Tpo) in promoting hematopoiesis has been extensively studied in late fetal, neonatal, and adult mice. However, the effects of Tpo on early yolk sac hematopoiesis have been largely unexplored. We examined whole embryos or the cells isolated from embryo proper and yolk sacs and identified both Tpo and c-mpl (Tpo receptor) mRNA transcripts in tissues as early as embryonic day 6.5 (E6.5). Pre-somite whole embryos and somite staged yolk 
INTRODUCTION
Thrombopoietin (Tpo) is a hematopoietic growth factor that stimulates the proliferation and differentiation of hematopoietic stem cells, primitive progenitors, megakaryocytes, and platelets [1] [2] [3] [4] . The cellular receptor for Tpo, c-mpl, belongs to the cytokine receptor super family 5 . Early studies employing antisense oligonucleotides to disrupt c-mpl function suggested that the effects of Tpo may be restricted to megakaryocytic progenitor cells 6 . A platelet lineagerestricted action of Tpo on c-mpl expressing cells was also observed in animals treated with Tpo 7 . Mutant mice in which the genes for Tpo or c-mpl have been disrupted display a similar phenotype with deficient megakaryopoiesis. Both mutant strains suffer from thrombocytopenia with 100% penetrance. No significant difference in the number of other blood cells, including red blood cells, neutrophils, lymphocytes, monocytes and eosinophils has been observed in either mutant strain 8 .
Expression of c-mpl has subsequently been demonstrated on hematopoietic stem cells 9 .
In vivo administration of Tpo to normal and myelosuppressed mice has also been reported to cause multi-lineage effects 10 . Transplantation of c-mpl-/-mutant mice marrow into lethally irradiated recipients results in poor repopulating ability by these donor cells 11 . Tpo has recently been found to expand HSC in vitro as evidenced by higher levels of donor cell engraftment posttransplantation into lethally irradiated mice compared with freshly transplanted marrow cells 12 .
These results have demonstrated that the effects of Tpo on hematopoiesis are more diverse than originally reported.
Although much has been learned about the role of Tpo in fetal liver and adult marrow hematopoiesis, little is known of the effect of Tpo on early yolk sac hematopoiesis. Tpo has been reported to enhance the proliferation and differentiation of erythroid cells in the presence or
For personal use only. on August 31, 2017 . by guest www.bloodjournal.org From absence of erythropoietin in cultured day 10.5 post coitus (pc) yolk sac cells 13 . In other studies, the addition of Tpo to embryonic stem cell (ES) cultures during the growth of embryoid bodies (EB) resulted in a significant increase in the total number of hematopoietic progenitors generated by day 6 EBs. However, the presence of Tpo in EB cultures resulted in a dramatic decrease in erythroid CFU activity 14 . Because the pattern and kinetics of erythropoiesis in the murine ES differentiation system largely mirror those of the murine yolk sac, the results of the two studies above appear to be contradictory 15 .
We have examined the effects of Tpo on hematopoietic progenitor cell growth in vitro in cells isolated from the early murine embryo and from isolated yolk sac and embryo proper cells.
We report that Tpo causes dose dependent inhibition of primitive and definitive erythroid CFU growth but enhances mixed lineage and megakaryocytic CFU growth in vitro in cells derived from early embryos and extraembryonic yolk sacs.
MATERIALS AND METHOD

Mice maintenance
C57BL/6J mice were purchased from Jackson Laboratory (Bar Harbor, ME). Gpi/BoyJ mice were derived from B.6Gpi-1A (gift of Dr. David Harrison, Jackson Labs, Bar Harbor, ME)
× B.6SJL-Pep3B/Boy/J (purchased from Jackson Labs) breeding. The F1 progeny were screened for expression of glucose phosphate isomerase 1A (Gpi-1A) enzyme activity as previously described 16 and CD45.1 expression on peripheral blood leukocytes by FACS. To obtain timed pregnant mice, two females were caged with a male overnight, and then examined for the evidence of a copulation plug the next morning. The care and use of animals in these studies 
Yolk sac cell preparation
Timed-pregnant mice were killed by CO 2 inhalation and the uteri were removed from the peritoneum and washed with phosphate buffered saline or Hank's balanced salt solution (GibcoBRL, Gaithersburg, MD) several times. Embryos were obtained and embryo proper and yolk sac were isolated as described previously 17 . Presomite embryos were staged by morphological criteria 18 . Embryos were staged by somite counting 19, 20 . Dissected embryo proper or yolk sac were incubated with 0.1% collagenase/dispase (Sigma, St. Louis, MO) in 20% fetal bovine serum (FBS, Hyclone, Logan, UT) for 1-1.5 hour at 37°C, and dispersed yolk sac or embryo proper were drawn through a 70µm strainer, deposited into a polystyrene tube, and spun at 500g for 10 minutes. The pellet was washed with Iscove's modified Dulbecco's medium (IMDM) with 10% FBS, 2% penicillin and streptomycin (pen/strep, GibcoBRL), 2mM
glutamine and 450µM monothioglycerol (MTG, GibcoBRL) and centrifuged again at 500g for 10 minutes. Cells in the suspension were counted and viability tested via Trypan blue (GibcoBRL) exclusion criteria.
RNA preparation and reverse transcriptase -polymerase chain reaction (RT-PCR)
RNA was isolated from yolk sac and embryo proper using TRIzol Reagent (GibcoBRL) 
Primitive erythroid colony assay
Cells were plated in duplicates or triplicates at 1-2.5×10 5 cells/ml in 0.9% methylcellulose-based media (StemCell Technologies, Vancouver, Canada) which included IMDM, 2mM glutamine, 1% pen/strep, 5% protein free hybridoma medium-II (PFHM-II, GibcoBRL), 50µg/ml ascorbic acid, 450µM MTG, 200 µg/ml iron-saturated holo-transferrin (Sigma), 15% plasma derived serum (Animal Technology, Antech, TX), 4U/ml recombinant human erythropoietin (Epo, Amgen, Thousand Oaks, CA), and ± 50ng/ml recombinant human Tpo (Peprotech, Rocky Hill, NJ). Cultures were incubated in a humidified incubator at 37°C in 5% CO 2 and colonies were counted on day 7 24 .
Definitive committed progenitor assay
Cells were plated in duplicates or triplicates at 1-2.5×10 5 cells/ml in 0.9% methylcellulose-based media which included IMDM, 2mM glutamine, 1% pen/strep, 10 -5 Mmercaptoethanol, 30% fetal bovine serum, 4U/ml recombinant human Epo (Amgen, Thousand
Oaks, CA), 100U/ml recombinant murine interleukin-3 (IL-3, Peprotech), 100ng/ml recombinant For personal use only. on August 31, 2017 . by guest www.bloodjournal.org From murine stem cell factor (SCF, Peprotech), and ± 50ng/ml recombinant human Tpo (Peprotech).
Cultures were incubated in a humidified incubator at 37°C in 5% CO 2 in air and colonies were counted on day 7 22, 25 .
CFU-Meg and BFU-Meg assay and Immunohistochemical staining
Cells were plated in duplicates or triplicates at 1-2.5×10 5 cells/ml in 0.3% agar-based
McCoy's 5A medium (GibcoBRL) 26 which included 10% fetal bovine serum, 100U/ml recombinant IL-3, and ± 50ng/ml recombinant human Tpo. Cultures were incubated in a humidified incubator at 37°C in 5% CO 2 in air 26 . After 7 days (for CFU-Meg) or 14 days (for BFU-Meg) incubation, these 35mm grid culture dishes were air dried over night and fixed with 1:3 methanol: acetone (Fisher, Fair Lawn, NJ). Fixed cultures were rehydrated in pH7.6, 0.05M Tris/0.15M NaCl buffer for 20 minutes, followed by additional 0.5ml 5% mouse serum for 20 minutes. Primary antibody (10 µg/ml rat anti-mouse CD41, PharMingen, San Diego, CA) or rat IgG isotype control antibody (5 µg/ml rat IgG2a, PharMingen) in Tris/NaCl buffer with 5% mouse serum was added to the cultures and incubated for 30 minutes. After washing, secondary antibody (10 µg/ml biotinylated anti-rat IgG, Vector, Burlingame, CA) was added and incubated for 30 minutes, followed by 18 µg/ml alkaline phosphatase streptavidin (Vector) for 30 minutes.
Plates were washed and subjected to alkaline phosphatase substrate (Vector) according to the manufacturer's instruction. Gently rinsed plates and colonies were scored after drying. CFUMeg and BFU-Meg were scored based on their colony morphology and CD41 expression.
Neutralizing antibody blocking studies
Anti-murine Tpo neutralizing antibody or anti-human Tpo neutralizing antibody or isotype control antibody (Peprotech) were incubated with murine Tpo or human Tpo (Peprotech)
at 37°C for 1 hour, respectively. Then, the mixture of antibody and cytokine were added to the For personal use only. on August 31, 2017. by guest www.bloodjournal.org From regular culture medium for primitive erythroid, definitive committed progenitor, and megakaryocyte assays and plated as described above.
Colony morphology analysis
CFU-Mix from definitive committed progenitor assay were plucked and digested in 50µl 0.25% trypsin (StemCell Technologies, Vancouver, Canada) for 2 minutes and diluted in 100µl IMDM with 10% serum. The single cell suspension was added to 100 µl 10% BSA (Ortho Clinical Diagnostics, Paritan, NJ) and centrifuged onto glass microscope slides at 500 rpm in a Cytospin (Shandon, England) device for 5 minutes. After air-drying, slides were fixed and stained with Diff-Quik Stain Set (Dade Behring, Dudingen, Switzerland). Cells were scored morphologically under oil-immersion light microscopy.
G1E-ER2 erythroid cell line
G1E-ER2 cells have been previously described [27] [28] [29] . These cells were grown in Iscove's Modified Dulbecco's Medium (IMDM) (Invitrogen) with 15% heat inactivated fetal bovine serum (Fisher), recombinant Epo (2u/ml) (Amgen, Thousand Oaks, CA), recombinant mouse (rm) SCF (50 ng/ml) (Amgen, Thousand Oaks, CA).
Apoptosis analysis on G1E-ER2 cells
G1E-ER2 cells were starved for 5 hours of growth factors and serum and cultured for 48 hours in the presence of 50 ng/ml of SCF or TPO or 2 U/ml of Epo. Apoptosis was measured by staining the cells with Annexin and analyzed by flow cytometry. Briefly, cells were resuspended in 100 µl of 1X binding buffer and 5 µl of Annexin V. Cells were then vortexed and incubated for 15 minutes at room temperature. After which an additional 400 µl of 1X binding buffer was added, and cells were analyzed by flow cytometry as described before 28 .
Immunoprecipitation
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From G1E-ER2 cells were starved for 6 hours at 37°C and stimulated with 500 ng/ml of TPO for indicated times or left unstimulated. Cells were lysed and equal amount of protein was subjected to immunprecipitation using an anti-murine Mpl antibody (kindly provided by Frederic J. de Sauvage, Genetech Inc, South San Francisco, CA) and western blot analysis was performed with an anti-phosphotyrosine antibody as described previously 28 .
Statistical analysis
Data are expressed as the mean ± SEM where applicable. Differences between groups were analyzed by means of a non-parametric Mann-Whitney test. A probability value of less than 0.05 was considered significant. All experiments were performed in triplicate on two to four experiments.
RESULTS
Tpo and c-mpl are expressed in early embryonic development
We examined early whole embryos for Tpo and c-mpl mRNA expression. For E6.5 and E7.0 embryos, the whole embryos were used for RNA extraction. 
Tpo diminishes primitive and definitive erythroid CFU formation but enhances mixed lineage and megakaryocyte CFU enumeration
To determine the effect of Tpo on early hematopoietic progenitor formation in vitro, we examined primitive and definitive erythroid CFU growth. In E7.5 whole embryos, only primitive erythroid CFU (EryP) can be detected (Fig. 2a) . In E8.25 whole embryo and E8.5 yolk sac, both primitive and definitive CFU cells can be detected (Fig. 2b and 2c ). In the E9.5 yolk sac, primitive erythroid CFU had disappeared and only definitive CFU were enumerated in culture (Fig. 2d) . The presence of Tpo in the culture system resulted in a decreased number of EryP in cultured E7.5 and E8.25 whole embryo and E8.5 yolk sac and embryo proper cells (Fig.   2a, 2b and 2c ). Tpo also decreased the output of definitive erythroid CFU cells (BFU-E) in E8.25 whole embryo and E8.5 and E9.5 yolk sac cell cultures (Fig. 2b, 2c and 2d ). However, the presence of Tpo in the same cultures augmented the number of CFU-Mix enumerated in E8.25 whole embryo and E8.5 and E9.5 yolk sac cell cultures (Fig. 2b, 2c and 2d ).
As anticipated, Tpo increased the production of both CFU-Meg and BFU-Meg in E8.25 whole embryo and E8.5 and E9.5 yolk sac cell cultures (Fig. 2b, 2c and 2d) . We also identified colonies in cultures containing E8.5 and E9.5 embryo proper cells. Although the number of CFU enumerated was much lower than that of yolk sac (Table 1) , Tpo diminished BFU-E output by 50%, had no effect on CFU-Mix, and increased CFU-and BFU-Meg by 2-fold. Table 1 .
Progenitor number per E8.5 or 9.5 embryo proper cultured in the presence or absence of 50ng/ml Tpo. 
isolated from these early embryos. Except for CFU-GM, all CFU responded to added Tpo in a dose dependent fashion. BFU-E and EryP CFU decreased in a reciprocal fashion as the concentration of Tpo increased in the cultures containing E8.5 or E9.5 yolk sac cells (Fig. 3a and   3b ). On the contrary, CFU-Mix and CFU-Meg frequencies linearly increased with increasing concentrations of added Tpo (Fig. 3b) . Therefore, colony formation of EryP, BFU-E, CFU-Mix and CFU-Meg are responsive to Tpo over a wide range of concentrations, while CFU-GM appeared unresponsive (data not shown). 
Effect of anti-Tpo neutralizing antibody on Tpo modulation of CFU formation
To further substantiate that the effects of Tpo on hematopoietic progenitor formation are a direct effect of Tpo, we examined the consequences of the addition of an antibody that binds to For personal use only. on August 31, 2017. by guest www.bloodjournal.org From and neutralizes Tpo action by blocking binding of Tpo to c-mpl. Because of the endogenous expression of Tpo and c-mpl, we first confirmed that addition of the anti-murine Tpo neutralizing antibody (anti-mTpo) to cultures had no effect on baseline CFU formation (Table 2) . Table 2 .
Addition of anti-murine Tpo neutralizing antibody to cultures has no effect on baseline CFU formation. Increasing concentrations of neutralizing antibody completely rescued EryP colony numbers in the presence of hTpo, while a control antibody did not show any effect (Fig. 4a) . Similarly, BFU-E colony numbers were significantly increased by adding anti-hTpo neutralizing antibody in hTpo-supplemented cultures to the level approaching those cultures containing no hTpo (Fig.   4b ). However, anti-hTpo neutralizing antibody decreased the number of CFU-Mix and CFUMeg in cultures with added hTpo (Fig. 4a and 4b ). CFU-GM formation was the same in cultures with or without addition of anti-hTpo neutralizing antibody or control antibody (data not shown). 
EryP
BFU-E CFU-Mix
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While the effect of Tpo was not apparent on CFU-Mix formation in these experiments, the effects of Tpo on BFU-E and megakaryocyte colonies was similar to the results obtained when ckit+CD34+ yolk sac-derived cells were plated in a bulk progenitor assays and supports a direct effect of Tpo on these progenitor cells.
Effect of Tpo on late yolk sac and adult marrow CFU
Given the evidence that Tpo has a positive effect on E10.5 yolk sac and adult marrow erythroid CFU formation 10, 13, 30 , we also examined the effect of Tpo on late yolk sac and adult marrow progenitors under our culture conditions. In E10.5 embryo proper (Fig 5a) , few colonies were identified; a finding consistent with previous studies 19 . Significantly, more colonies were found in plated E10.5 yolk sac cell cultures (Fig 5b) . Tpo did not alter BFU-E and CFU-Mix formation, but CFU-Meg significantly increased (Fig. 5b) .
For Figure 5 . Effect of Tpo on E10.5 embryo, yolk sac and adult bone marrow BFU-E, CFUMix, CFU-GM, and CFU-Meg. E10.5 embryo (a) and yolk sac (b) cells at 10,000 cells/ml and adult bone marrow cells (c) at 50,000 cells/ml were plated in the progenitor assay (as described in the materials and methods) in the presence or absence of 50ng/ml Tpo. * P<0.05, -Tpo compared to +Tpo.
To further characterize the lack of effect of Tpo on BFU-E formation at the functional and biochemical level, we utilized an ES cell derived erythroid progenitor cell line, G1E-ER2 [27] [28] [29] .
These cells were derived from in vitro differentiated GATA-1-/-ES cells and represent primary GATA-1-/-erythroblasts as determined by the expression of erythroid, but not myeloid genes 27 .
Remarkably, restoration of GATA-1 function in these cells restores erythroid maturation 27, 28 .
Utilizing these cells, we examined the effect of Tpo in augmenting or inhibiting cell survival and proliferation, alone, or in the presence of SCF and Epo. As seen in Figure 6b Murine hematopoiesis arises in yolk sac blood islands and becomes morphologically identifiable at E7.0-7.5 31, 32 . At first, primitive erythroid progenitors comprise nearly all blood island progenitors, however, definitive progenitors begin to emerge at E8.25 33 . We have antibody, the biologic effects of the growth factor were abrogated in every experimental group.
Interestingly, the inhibitory effect of hTpo on BFU-E formation was totally rescued by adding 0.5 µg/ml anti-hTpo neutralizing antibody in the hTpo supplemented culture system (Fig. 4b) .
However, the inhibitory effect of hTpo on EryP formation was not totally rescued using the same concentration of neutralizing antibody (Fig. 4a) . At the same time, the positive effect of hTpo on CFU-Mix and CFU-Meg formation was also not totally abolished by 0.5 µg/ml anti-hTpo neutralizing antibody (Fig. 4b ). These observations may be explained by varying sensitivities of different progenitors to Tpo.
We did not observe an effect of Tpo on E10.5 yolk sac erythroid progenitor cells, as previously noted by Era et al. 13 . This may be explained by the different serum and cytokines that we used in our study. We also failed to see any effect of Tpo on our erythroblast cell line despite the evidence of c-Mpl receptor activation. We did observe a positive effect of Tpo on BFU-E formation in plated adult marrow cells. This effect is similar to that observed when mice deficient in Tpo expression (Tpo-/-mice) were treated with exogenous Tpo. While the lack of Tpo (Tpo-/-) resulted in diminished BFU-E, CFU-Mix, CFU-and BFU-Meg progenitor cell numbers, all of these progenitor compartments were rescued to greater than wild-type control levels when exogenous Tpo was administrated in vivo 34 . These results indicate that Tpo differentially affects erythroid CFU formation depending on the stage and site of hematopoietic development in the mouse whereas the effects of Tpo on CFU-Mix and CFU-and BFU-Meg are similar throughout murine ontogeny.
There are several possibilities to explain the mechanism through which Tpo simultaneously inhibits erythroid but augments mixed lineage and megakaryocyte CFU formation in the early embryo. First, Tpo might send an inhibitory signal to erythroid precursors but a growth progression signal to mixed lineage and megakaryocyte progenitors directly or indirectly, although whether this is true or not need to be further studied. As noted above, we did not observe a Tpo induced apoptotic response in cultured erythroid cells. Alternatively, similar to the in vitro study of ES cell-derived hematopoiesis 14 , the idea of bi-potent clonogenic precursor for both erythroid and megakaryocyte [35] [36] [37] [38] Cooper for helping us with the megakaryocyte assays. We appreciate Pat Fox for her editorial assistance and document preparation.
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